Explore Products
Primary Cells

Human Acute Myeloid Leukemia Peripheral Blood Mononuclear Cells (Newly Diagnosed)

  • BSL

    1

  • 181
PBMCs are isolated from Acute Myeloid Leukemia-PB by diluting the blood with phosphate-buffered saline and using gradient separation techniques. After centrifugation, the Mononuclear Cells layer is collected. Acute Myeloid Leukemia Peripheral Blood Mononuclear Cells are available in the newly diagnosed and relapsed/refractory stages.
Request Your Custom Quote Today

Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.

Get a Quote
  • High Purity Levels
  • Precision and Reliability
  • Customization Options
Species

Human

Cat.No

ABC-TC3028

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Product Category Primary Cells
Size/Quantity

1 vial

Cell Type

Mononuclear Cell

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Acute Myeloid Leukemia

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Diseased Human Peripheral Blood Mononuclear Cells

Description

Human Acute Myeloid Leukemia Peripheral Blood Mononuclear Cells (Newly Diagnosed) are isolated from the peripheral blood of newly diagnosed acute myeloid leukemia (AML) patients. The mononuclear cell-rich PBMC layer is separated from diluted whole blood by gradient centrifugation. The cell morphology shows a heterogeneous cell population with a single nucleus, including immature myeloid progenitor cells, monocytes and a small number of lymphocytes.Cytogenetic analysis of these cells commonly reveals chromosomal abnormalities such as t(8;21), inv(16), or monosomy 7, depending on the patient. In in vitro culture, this cell population shows the characteristics of coexistence of adherent growth and suspended growth, and some myeloid progenitor cells can differentiate into leukemic blasts with diverse morphologies These cells typically express CD34, CD33, and HLA-DR, detectable via flow cytometry.They are tumorigenic and can initiate leukemic proliferation when engrafted into immunodeficient mice.

View Product Image

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Application

  • Human Acute Myeloid Leukemia Peripheral Blood Mononuclear Cells (Newly Diagnosed) can serve as an in vitro cell model to investigate the pathogenesis of de novo AML and developing novel therapeutic strategies. They also provide a platform for investigating immune evasion mechanisms and developing immunotherapies, such as assessing CAR-T/NK cell cytotoxicity and characterizing immune checkpoint expression patterns.

Inquiring Human Acute Myeloid Leukemia Peripheral Blood Mononuclear Cells (Newly Diagnosed)

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button